Sign up to see all 5.
Sign up to see all 5.
Sign up to see all 5.
Every notice on Red Flags →A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
B
BlackRock, Inc.
|
3.1M | 5.93% | −809.1K (−20.7%) | ≤2021 | 0.0% | |
|
Shares held by quarter
Peak holding3.9M (Q4'25)
Change over 8 quarters−294.7K
Share of the company5.930%
|
||||||
|
VP
Vanguard Portfolio Management LLC
|
2.0M | 3.79% | −74.7K (−3.6%) | ≤2021 | 0.0% | |
|
Shares held by quarter
Peak holding2.1M (Q1'26)
Change over 8 quarters+2.0M
Share of the company3.790%
|
||||||
28 more super investors behind a free account
See every manager holding Axsome Therapeutics, Inc., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$340M | 1.4M | 2.65% | 0.01% | June 30, 2026 |
|
VS
Vanguard Index Funds
|
$246M | 1.0M | 1.92% | 0.13% | June 30, 2026 |
23 more funds behind a free account
See every fund holding Axsome Therapeutics, Inc. and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
TH
Tabuteau Herriot
Insider
|
14.7M | 28.06% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company28.060%
|
||||||
|
CM
Coleman Mark
Insider
|
832.2K | 1.59% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company1.590%
|
||||||
4 more holders behind a free account
See every insider and 5%+ holder of Axsome Therapeutics, Inc..
Sign up freeLoading...